publication venue for
- Decision Regret Following the Choice of Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: A Prospective Cohort Study. 34:626-634. 2024
- A Multicentre Retrospective Study of Anaplastic Thyroid Cancer in the Era of Targeted Therapy in a Public Health Care System: Canada's Experience. 33:1374-1377. 2023
- Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy. 33:1119-1123. 2023
- A Quantitative Analysis Examining Patients' Choice of Active Surveillance or Surgery for Managing Low-Risk Papillary Thyroid Cancer. 32:255-262. 2022
- Response to Miyauchi et al. re: “A Prospective Mixed-Methods Study of Decision Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer”. 30:1542-1543. 2020
- A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer. 30:999-1007. 2020
- Risk for Thyroid Cancer Recurrence Is Higher in Men Than in Women Independent of Disease Stage at Presentation. 30:871-877. 2020
- A Systematic Review and Meta-Analysis of Subsequent Malignant Neoplasm Risk After Radioactive Iodine Treatment of Thyroid Cancer. 28:1662-1673. 2018
- An Exploratory Study of Fatigue and Physical Activity in Canadian Thyroid Cancer Patients. 27:1156-1163. 2017
- Long-Term Efficacy of Modified-Release Recombinant Human Thyrotropin Augmented Radioiodine Therapy for Benign Multinodular Goiter: Results from a Multicenter, International, Randomized, Placebo-Controlled, Dose-Selection Study. 24:727-735. 2014
- Activated Leukocyte Cell Adhesion Molecule Is a Marker for Thyroid Carcinoma Aggressiveness and Disease-Free Survival. 23:201-208. 2013
- The Rationale of Patients with Early-Stage Papillary Thyroid Cancer for Accepting or Rejecting Radioactive Iodine Remnant Ablation. 23:246-247. 2013
- Visual Abilities at 6 Months in Preterm Infants: Impact of Thyroid Hormone Deficiency and Neonatal Medical Morbidity. 20:309-315. 2010
- Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysis. 19:451-457. 2009
- Impact of Neonatal Thyroid Hormone Insufficiency and Medical Morbidity on Infant Neurodevelopment and Attention Following Preterm Birth. 19:395-401. 2009
- Regional Differences in Opinions on Adjuvant Radioactive Iodine Treatment of Thyroid Carcinoma within Canada and the United States. 17:1235-1242. 2007
- Second Primary Malignancy Risk in Thyroid Cancer Survivors: A Systematic Review and Meta-Analysis. 17:1277-1288. 2007
- The Effect of Adding a Surfeit of Autologous CD8+T Cells to SCID Mice after Secondary Rexenografts of Graves' Thyroid Tissue. 6:429-436. 1996
- A New Mutation in the Thyroid Hormone Receptor (TR) β Gene (V458A) in a Family with Resistance to Thyroid Hormone (RTH). 6:311-312. 1996